Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting

Clinical trial NCT00371215 · COMPLETED

Trial details

NCT number: NCT00371215
Sponsor: ZymoGenetics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Surgical Hemostasis

Start date: 2006-08-01
Primary completion: 2007-06-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.